These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3235442)

  • 1. Hemochromatosis--secondary prevention.
    Mehta BC
    J Assoc Physicians India; 1988 Dec; 36(12):741. PubMed ID: 3235442
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening in primary health care. Presentation of a case of familial hemochromatosis].
    Ibáñez Estella JA; Sánchez Ibáñez A; Rubio Montañés ML; Malumbres Juarros P; Izquierdo Clemente C
    An Med Interna; 1992 Oct; 9(10):516. PubMed ID: 1420767
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary hemochromatosis--an overlooked disease?].
    Milman N
    Ugeskr Laeger; 1982 Jul; 144(28):2071-4. PubMed ID: 6755843
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemochromatosis--should genetic testing be a routine?].
    Ulvik RJ
    Tidsskr Nor Laegeforen; 1998 Feb; 118(6):946. PubMed ID: 9543813
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemochromatosis.
    Allanson JE
    Ariz Med; 1984 Apr; 41(4):226-8. PubMed ID: 6743031
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemochromatosis--molecular genetic screening of blood donors?].
    Tranebjaerg L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2993-5. PubMed ID: 9748841
    [No Abstract]   [Full Text] [Related]  

  • 8. [Idiopathic hemochromatosis. Immunogenetics and diagnosis. Prevention by HLA genotypes].
    Fauchet R; Lemignon L; Bourel M; Genetet B; Simon M
    Pathol Biol (Paris); 1986 Jun; 34(6):715-21. PubMed ID: 3531987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for hemochromatosis?
    Lederle FA
    J Gen Intern Med; 1989; 4(1):61-3. PubMed ID: 2915275
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for hemochromatosis.
    Kushner JP
    Gastroenterology; 1995 Jul; 109(1):315-6. PubMed ID: 7797031
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.
    Baer DM; Simons JL; Staples RL; Rumore GJ; Morton CJ
    Am J Med; 1995 May; 98(5):464-8. PubMed ID: 7733125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Should we screen for hemochromatosis? Critical analysis of the literature].
    Charvet-Protat S; Yaouanq J; Fleurette F
    Rev Epidemiol Sante Publique; 1997 Sep; 45(4):315-27. PubMed ID: 9380912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic hemochromatosis: importance of population screening?].
    Cartabellotta A; Montalto G
    Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic screening discovers hemochromatosis. Organ damage caused by iron may be prevented].
    Olsson KS
    Lakartidningen; 1997 Oct; 94(44):3957-8. PubMed ID: 9411162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hereditary primary hemochromatosis or hemochromatosis secondary to alcoholic cirrhosis? Observation of a case complicated by malignant hepatoma and thrombosis of the portal vein].
    Tyrer JH; Powell LW; Burnett W
    Presse Med (1893); 1966 Apr; 74(22):1135-6. PubMed ID: 4286281
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of transfusion hemochromatosis].
    Aul C; Gattermann N; Jaeger M
    Internist (Berl); 1997 Sep; 38(9):865-6. PubMed ID: 9410837
    [No Abstract]   [Full Text] [Related]  

  • 18. Physicians dumping iron.
    Lindenmayer JM
    Med Health R I; 1997 Aug; 80(8):266-7. PubMed ID: 9283184
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin.
    Whitington PF; Kelly S
    Pediatrics; 2008 Jun; 121(6):e1615-21. PubMed ID: 18474533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preclinical hereditary hemochromatosis--is there an indication for preventive screening?].
    Grønbaek KE; Milman N; Skødt V
    Ugeskr Laeger; 1995 Jul; 157(30):4249-50. PubMed ID: 7653009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.